TRASTUZUMAB EMTANSINE 100 mg (Ujvira) Injection

Name: Trastuzumab Emtansine 100 mg (Ujvira) Injection
Brand: Ujvira
Price: 455.00 USD
Availability: InStock

~~$900.00~~ $455.00

Prescription Required

Trastuzumab emtansine is an antibody-drug conjugate used to treat selected HER2-positive breast cancers. It works by targeting HER2 proteins on cancer cells and delivering an anticancer medicine directly into them, helping slow or stop their growth.

Generic Name	TRASTUZUMAB EMTANSINE
Strength	100 mg
Manufacturer	Zydus
Packing	1 Vial
Prescribed For	Treat HER2-positive early and metastatic breast cancer
Availability	In Stock
Shipping to	USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, Japan, UAE, Saudi Arabia, Qatar, Kuwait, Georgia, Mexico, and many other countries.

Genuine Medicines

Quick Air Delivery

Secure Payment

24/7 Support

Uses of Trastuzumab Emtansine

Advanced HER2-positive breast cancer
Metastatic HER2-positive breast cancer
Residual HER2-positive early breast cancer

Benefits of Trastuzumab Emtansine

Targets HER2-positive cancer cells
Delivers chemotherapy inside targeted cells
Helps slow cancer progression

How Does Trastuzumab Emtansine Work?

The trastuzumab component attaches specifically to HER2 proteins on cancer cells. The medicine is then taken inside the cell, where it releases the chemotherapy component DM1. DM1 blocks microtubules, preventing the targeted cancer cell from dividing.

Possible Side Effects

Fatigue
Nausea
Reduced platelets
Increased liver enzymes
Headache

Precautions

Heart function must be monitored.
Liver tests and blood counts are required.
Report breathing problems or unusual bleeding.
Do not substitute with standard trastuzumab.
Avoid pregnancy and breastfeeding.

Trastuzumab Emtansine Price and Reimbursement Information by Country

Trastuzumab Emtansine prices may vary between countries depending on the brand, strength, pack size, pharmacy, insurance coverage, government subsidies, taxes and local healthcare policies. The following resources provide country-specific pricing, reimbursement, regulatory or medicine information.

View medicinal-form and pricing information on NICE BNF (UK) – https://bnf.nice.org.uk/drugs/trastuzumab-emtansine-specialist-drug/medicinal-forms/
View Kadcyla medicine information on Drugs.com (USA) – https://www.drugs.com/kadcyla.html
View PBS pricing and subsidy information (Australia) – https://www.pbs.gov.au/medicine/item/11951B-10281D-11956G-10282E
View current Kadcyla prescribing information on DailyMed (USA) – https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=human&query=KADCYLA

Author

Reviewed By

Dr. Abhinav Narang

Doctor of Medicine (MD) | Professional Interest in Oncology

Dr. Abhinav Narang holds a Doctor of Medicine (MD) degree and has a professional interest in oncology and cancer care. His interests include anticancer therapies, monitoring treatment response, managing treatment-related side effects and providing supportive care throughout the patient’s treatment journey.

Disclaimer

This website operates in compliance with applicable pharmaceutical laws. All content and data available on this website are intended solely for informational purposes. The information provided is not a substitute for professional medical advice, diagnosis, or treatment. Information provided here is for general awareness and does not replace medical advice. We strongly encourage you to consult a qualified healthcare professional for guidance.